Post Profile






Mylan Agrees to Pay $465 Million for Ripping Off Medicare on EpiPens, Stock Price Soars

Mylan, the drug company that makes EpiPen, has been overcharging Medicare and Medicaid for years. But today the pharmaceutical company had to finally pay the piper. In a deal announced by the notorious price-gougers, Mylan will hand over $465 million to the government, but it won’t have to admit any wrongdoing. Read more...
read more

share

Related Posts


Lawmakers are accusing Mylan of overcharging Medicaid for the EpiPen — and the stock is tanking (MYL)

Business & Finance : Business Insider: Money Game

Mylan could be facing another issue when it comes to the EpiPen, a drug used to treat severe allergic reactions that has seen a price increase of more than 500% since 2007. The company's stock was down by more than 4% Friday shortly...

EpiPen Maker Mylan Will Pay $465 Million to Settle Medicaid Overcharging Case

Business & Finance : DealBook

Mylan said the settlement, after the government had said it improperly classified EpiPen as a generic drug, did not imply any admission of wrongdoing.

Mylan to pay $465-million settlement over Medicaid EpiPen rebates

Business & Finance : LA Times: Business

Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen allergy injection. The federal government says EpiPen is a branded drug, which means Mylan should have been paying a far higher...

The maker of EpiPen has agreed to pay the government $465 million after allegedly overcharging for the medicine

Business & Finance : Business Insider: Money Game

Mylan, the marker of the EpiPen, has agreed to pay the federal government a $465 million settlement after it allegedly overcharged government healthcare agencies for the medicine, according to a release from the firm. Mylan had unde...

Mylan to pay $465 million over Medicaid pricing of EpiPen

Business & Finance : Mashable: Business

Mylan will pay the Department of Justice $465 million in a settlement over its pricing and classification of the EpiPen through Medicaid, the pharmaceutical company announced Friday.  Mylan, which came under fire this summer for sys...

Comments


Copyright © 2016 Regator, LLC